Advances in haemodynamic monitoring to better manage your moderate to high risk surgical patients

 
Loading

Advances in haemodynamic monitoring to better manage your moderate to high risk surgical patients

09 Nov 2021
Hands on Training zone 1

2.4 million patients undergo high risk surgery across Europe every year 20% experience complications. Utilising advanced haemodynamic monitoring with a protocol has been shown to reduce post-operative complications in moderate to high risk surgery.

Station names:

Ø  Predicting hypotension to reduce IOH

Ø  Non-invasive continuous pressure and flow monitoring

Non-invasive cerebral and somatic tissue oximetry 

Speakers
Stuart Sanderson, Business Unit Manager - Edwards Lifesciences
Edward Hembrow, Clinical Innovation Manager - Edwards Lifesciences
Felicity Fowler, Key account manager - Edwards Lifesciences
GOLD SPONSOR

GOLD SPONSOR

  

GOLD SPONSOR

  • A. Menarini Farmaceutica Internazionale Srl

 

GOLD SPONSOR

  • Alexion Pharma

 

GOLD SPONSOR

  • BMS-Pfizer

 

GOLD SPONSOR

  • FUJIFILM SONOSITE

 

GOLD SPONSOR

SD

SILVER SPONSOR

  • Boston Scientific

 

SILVER SPONSOR

  • Bial Pharma

 

SILVER SPONSOR

  • The MDU

 

SILVER SPONSOR

  • MDDUS

 

SILVER SPONSOR

GF

SILVER SPONSOR

JK

SILVER SPONSOR

SILVER SPONSOR

  

Lanyard Sponsor

Lanyard Sponsor

      

Lanyard Sponsor

Lanyard Sponsor

      

Don't miss your chance to get involved